13F HOLDINGS REPORT
KCK LTD.
Quarter ended Q2 2023 · Filed May 5, 2023 · Accession 0001012975-23-000207
Total Value
$67.3M
Positions
3
Other Managers
0
Confidential Omitted
No
Holdings (3)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | SIGHT SCIENCES INC | SGHT | 4,715,562 | $41.2M | 61.22% |
| 2 | NEUROPACE INC | NPCE | 5,621,111 | $26.1M | 38.74% |
| 3 | AILERON THERAPEUTICS INC | RNTX | 22,341 | $27,703 | 0.04% |